Sponsor-CRO practices that facilitate the creation of a high-quality pathology report: a pharmaceutical sponsor's perspective. | Toxicol Pathol;39(6): 1013-6, 2011 Oct. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Sponsor-CRO practices that facilitate the creation of a high-quality pathology report: a pharmaceutical sponsor's perspective.

Irizarry Rovira, Armando R; Foley, George L; Clemo, Frances A.

Affiliation

Irizarry Rovira AR; Department of Pathology, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46225, USA. irizarryar@lilly.com

Toxicol Pathol ; 39(6): 1013-6, 2011 Oct.

Article in En | MEDLINE | ID: mdl-21971935

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pathology / Peer Review / Toxicology / Contract Services / Research Report Language: En Journal: Toxicol Pathol Year: 2011 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pathology / Peer Review / Toxicology / Contract Services / Research Report Language: En Journal: Toxicol Pathol Year: 2011 Document type: Article Affiliation country: Country of publication: